Premium
End‐Stage Renal Disease and Its Treatment in Venezuela
Author(s) -
BellorinFont Ezequiel,
Milanés Carmen Luisa,
RodríguezIturbe Bernardo
Publication year - 2002
Publication title -
artificial organs
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.684
H-Index - 76
eISSN - 1525-1594
pISSN - 0160-564X
DOI - 10.1046/j.1525-1594.2002.07062.x
Subject(s) - medicine , dialysis , transplantation , hemodialysis , diabetes mellitus , renal replacement therapy , mortality rate , population , cause of death , end stage renal disease , disease , rehabilitation , diabetic nephropathy , intensive care medicine , surgery , physical therapy , environmental health , endocrinology
In Venezuela there are 3,234 new cases (132 per million population [pmp]) requiring renal replacement therapy each year, and only 40% of these are admitted to the different modalities of dialysis. In the year 2000, there were 195 patients pmp in chronic hemodialysis (4,700 patients). Diabetes, glomerular diseases, and hypertension account for more than 60% of the patients in chronic dialysis. Gross mortality in hemodialysis is around 20%, and cardiovascular causes are the primary cause of death (39.5%). Hospital admission in the dialysis patients amounts to 4.6 days/patient/year. Rehabilitation is inadequate. Only 45% of the dialysis patients report normal home or work activities. Transplantation in Venezuela has a general graft survival rate of 83% at 1 year (90% for living related grafts) and 50% (64% for living related grafts) at 10 years. Future tendencies include emphasis in preventive strategies, including early detection and treatment of diabetes and hypertension, as well as efforts to increase the rate of renal transplantation.